This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tapanainen, J. M. Articles by Huikuri, H. V. Search for Related Content PubMed PubMed Citation Articles by Tapanainen, J. M. Articles by Huikuri, H. V.

Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era

Jari M. Tapanainen, MD^*, Kai S. Lindgren, MD^*, Timo H. Mäkikallio, MD^*, Olli Vuolteenaho, MD, Juhani Leppäluoto, MD and Heikki V. Huikuri, MD, FACC^*,*

^* Division of Cardiology, Department of Internal Medicine, Oulu University Hospital, Oulu, Finland
Department of Physiology, Oulu University, Oulu, Finland

View larger version (23K): [in a new window]   Figure 1 Kaplan-Meier survival curves for cardiac mortality of patient groups stratified by the results of natriuretic peptide and ejection fraction (EF) measurements: (A) for atrial natriuretic peptide (ANP), the best cut-off point was at the 60th percentile; (B) for N-terminal atrial natriuretic propeptide (N-ANP), the best cut-off point was at the 85th percentile; (C) for brain natriuretic peptide (BNP), the best cut-off point was at the 60th quartile; (D) for EF, the cut-off point was at the lowest quartile.

View larger version (14K): [in a new window]   Figure 2 Kaplan-Meier survival curves among patients with and without elevated brain natriuretic peptide (BNP).